Tepotinib M506 Metabolite - Request Quote
Tepotinib M506 Metabolite
| SZ CAT No: | SZ-T122002 |
| CAS No | NA |
| Mol.F. | C29H26N6O3 |
| Mol.Wt. | 506.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tepotinib M506 Metabolite is chemically 3-(1-(3-(5-((1-Methyl-2-oxopiperidin-4-yl)methoxy)pyrimidin-2-yl)benzyl)-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile. Tepotinib M506 Metabolite is supplied with detailed characterization data compliant with regulatory guideline. Tepotinib M506 Metabolite can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tepotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Tepotinib M506 Metabolite
Purchase Tepotinib M506 Metabolite
Tepotinib M506 Metabolite suppliers
Tepotinib M506 Metabolite manufacturers
Tepotinib M506 Metabolite price
Order Tepotinib M506 Metabolite
Enquire Tepotinib M506 Metabolite
Tepotinib M506 Metabolite cost
Tepotinib M506 Metabolite Supplier
Tepotinib M506 Metabolite Distributor
Tepotinib M506 Metabolite for Method Validation
Tepotinib Reference Standard
Tepotinib M506 Metabolite for ANDA Filing
Tepotinib M506 Metabolite for Forced Degradation Studies
Tepotinib M506 Metabolite Identification Standards
Tepotinib M506 Metabolite for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.